Evidence map›Paper›PMID 39561850›Full record

ArticleActa biomaterialia2025

MicroCT and contrast-enhanced microCT to study the in vivo degradation behavior and biocompatibility of candidate metallic intravascular stent materials.

Lisa Leyssens, Walid El Aazmani, Tim Balcaen, Pascal J Jacques, Sandrine Horman, Jeremy Goldman, Greet Kerckhofs

Abstract read
In one paragraph

Article in Acta biomaterialia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lisa LeyssensMechatronic, Electrical Energy and Dynamic Systems, Institute of Mechanics, Materials, and Civil Engineering, UCLouvain, 1348 Louvain-la-Neuve, Belgium; Pole of Morphology, Institute of Experimental and Clinical Research, UCLouvain, 1200 Woluwe-Saint-Lambert, Belgium. Electronic address: lisa.leyssens@uclouvain.be.
Walid El AazmaniPole of Morphology, Institute of Experimental and Clinical Research, UCLouvain, 1200 Woluwe-Saint-Lambert, Belgium. Electronic address: walid.elaazmani@gmail.com.
Tim BalcaenMechatronic, Electrical Energy and Dynamic Systems, Institute of Mechanics, Materials, and Civil Engineering, UCLouvain, 1348 Louvain-la-Neuve, Belgium; Pole of Morphology, Institute of Experimental and Clinical Research, UCLouvain, 1200 Woluwe-Saint-Lambert, Belgium; MolDesignS, Sustainable Chemistry for Metals and Molecules, Department of Chemistry, KU Leuven, 3001 Leuven, Belgium. Electronic address: tim.balcaen@kuleuven.be.
Pascal J JacquesMaterials and Process Engineering, Institute of Mechanics, Materials, and Civil Engineering, UCLouvain, 1348 Louvain-la-Neuve, Belgium. Electronic address: pascal.jacques@uclouvain.be.
Sandrine HormanPole of Cardiovascular Research, Institute of Experimental and Clinical Research, UCLouvain, 1200 Woluwe-Saint-Lambert, Belgium. Electronic address: sandrine.horman@uclouvain.be.
Jeremy GoldmanDepartment of Biomedical Engineering, Michigan Technological University, Houghton, MI 49931, USA. Electronic address: jgoldman@mtu.edu.
Greet KerckhofsMechatronic, Electrical Energy and Dynamic Systems, Institute of Mechanics, Materials, and Civil Engineering, UCLouvain, 1348 Louvain-la-Neuve, Belgium; Pole of Morphology, Institute of Experimental and Clinical Research, UCLouvain, 1200 Woluwe-Saint-Lambert, Belgium; Department of Materials Engineering, KU Leuven, 3001 Leuven, Belgium; Prometheus, Division of Skeletal Tissue Engineering, KU Leuven, 3000 Leuven, Belgium. Electronic address: greet.kerckhofs@uclouvain.be.

Funding

Biodegradable Metal Stent Alloys for Vascular ApplicationsR01HL168696 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Jeremy Goldman, Monica T Hinds · 2023 to 2026
$2.8M
NHLBI NIH HHS R01 HL168696
6 · The paper itself

Abstract

Biodegradable intravascular stents offer a promising alternative to permanent stents for treating atherosclerosis-related artery narrowing by potentially avoiding long-term complications. Identifying materials that degrade harmlessly and uniformly at a suitable rate is crucial. This study evaluated an advanced zinc alloy (Zn-Ag-Cu-Mn-Zr) alongside pure iron and pure zinc, using a simplified stent model of metallic wires implanted in the rat aorta. Assessments were made at 7, 24, and 84 days post-implantation using X-ray microfocus computed tomography (microCT) and contrast-enhanced microCT (CECT). For CECT, a contrast agent was chosen to provide optimal soft tissue contrast and minimal interaction with the wires. This combination of imaging techniques allowed us to evaluate degradation behavior, compare volume loss in various locations (outside the arterial lumen, inside the lumen, and encapsulated by neointima), compute degradation rates, and evaluate neointima tissue formation. Results showed that zinc and its alloy degrade less uniformly than iron, which demonstrates uniform surface degradation. The zinc alloy had a higher initial volume loss than the other materials but showed little increase over time. Neointima formation was similar for zinc and the zinc alloy, while iron provoked less tissue formation than both zinc and the reference cobalt-chromium alloy. Additionally, unlike cobalt-chromium and zinc, iron wires did not achieve consistent tissue encapsulation along their entire length, which may impair their performance. Mild inflammation was noted around zinc-based implants. Combining microCT and CECT provided 3D information on degradation uniformity, degradation products, and neointima morphometrics, highlighting the power of these imaging techniques to evaluate implant materials in a highly accurate way compared to previous 2D methods. STATEMENT OF SIGNIFICANCE: Biodegradable intravascular stents offer a promising solution to long-term complications associated with permanent stents by gradually dissolving in the body. To evaluate a novel zinc alloy (Zn-Ag-Cu-Mn-Zr) with improved mechanical properties, microstructure, and biocompatibility, we compared it to pure iron and zinc. We used advanced 3D imaging techniques, i.e., microCT and contrast-enhanced microCT, to assess the degradation behavior and the tissue response in a rat aorta model. The zinc alloy demonstrated promising properties despite less uniform degradation and mild inflammation compared to iron. Our findings highlight the superiority of 3D imaging over previously used 2D techniques in evaluating stent materials, offering critical insights into degradation processes and biocompatibility. These highly accurate measurements provide crucial information for developing improved biodegradable implants.

Indexed as

Biocompatible MaterialsContrast MediaRats, Sprague-DawleyStentsX-Ray MicrotomographyAbsorbable ImplantsAlloysAnimalsMaleMaterials TestingRatsZincAlloysBiocompatible MaterialsContrast MediaZincBiocompatibilityBiodegradable metallic intravascular stentContrast-enhanced microCTIn vivo degradation behaviorMicroctRat aortic model

Identifiers

PMID39561850
PMCPMC11670001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.